AGILENT
Agilent Technologies, Inc.
Application Filed: 2009-09-23
Trademark Application Details
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77833273 |
| Registration Number | 4085588 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Scott S. Havlick |
| Attorney Name | Scott S. Havlick |
| Attorney Docket Number | 77390.0647 |
| Law Office Assigned | L90 |
| Employee Name | ROSSMAN, WILLIAM M |
Timeline
| 1999-11-00 | Date of First Use |
| 2009-09-23 | Application Filed |
| 2011-11-01 | Published for Opposition |
| 2012-01-17 | Trademark Registered |
| 2017-05-04 | Location: TMEG LAW OFFICE 109 |
| 2017-05-04 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Agilent Technologies, Inc. |
| Address | 5301 Stevens Creek Boulevard Santa Clara DE 95051 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 3 |
| U.S. Codes: | 001,004,006,050,051,052 |
| International Codes: | 4 |
| U.S. Codes: | 001,006,015 |
| Type Code | Type |
|---|---|
| GS0011 | House mark for a full line of reagents for scientific or medical research use; house mark for a full line of chemicals for scientific purposes used in spectroscopy, mass spectrometry, chromatography and electrophoresis and for sample preparation for spectroscopy, mass spectrometry, chromatography and electrophoresis; chemicals used in industry and science, namely, for use in spectroscopy, mass spectrometry, chromatography, or electrophoresis or in sample preparation for spectroscopy, mass spectrometry, chromatography, or electrophoresis including standards all for scientific, clinical and scientific research use; reagents for scientific and research use; aqueous and organic solvents in the nature of chemical preparations for scientific and research use; cleaning detergents for industrial use, namely, for scientific and research use; chemicals for scientific purposes, namely, calibrants for performance verification of scientific instrumentation; ampholytes, namely, chemical products in the nature of preparations for scientific use for use in the separation and purification of any charge carrying molecule such as proteins and other molecules of biological origin as well as synthetic chemicals, these products being carrier ampholytes designed for use in isoelectric focusing, isotachophoresis and iso exchange chromatograph; chemicals, namely, buffer and standard solutions used in analytical chemistry; catalysts for chemical and biochemical processes; reagents, namely, matrices for scientific or medical research use; electrophoresis gels other than for medical or veterinary purposes; chromatography chemicals, namely, silica gel, polymers and solvents all for use in chromatography; purifying filtering and absorbing chemicals for use in industry, including for scientific and research use; solid phase extraction chemicals for use in the chromatography industry; chemical and biological standards, namely, chemical reagents for scientific and research use used in DNA, RNA and protein analysis; reagents for research purposes for scientific or medical research use; DNA labeling reagents for research purposes; DNA hybridization buffers, namely, reagents for research purposes for use in DNA hybridization; DNA cloning vectors, namely, reagents for scientific and research use; genomic cloning vectors, namely, reagents for scientific and research use; eukaryotic expression vectors, namely, reagents for scientific and research use; prokaryotic expression vectors, namely, reagents for scientific and research use; yeast shuttle vectors, namely, reagents for scientific and research use; competent cells, namely, reagents for scientific and research use; host cells, namely, reagents for scientific and research use; scientific and research laboratory reagents for molecular biological use, namely, packaging extracts used for inserting DNA into phages; polymerase chain reaction or PCR related products, namely, reagents for scientific and research use; nucleic acid markers, namely, reagents for scientific and research use; reagents used as protein standards for scientific, medical and research use; reagents used as synthetic peptide and protein digest standards for scientific and research use; reagents, namely, DNA primers and DNA vectors for scientific and research use; modifying enzymes not for medical use, namely, polymerase, nucleases, reverse transcriptases, ligases, kinases, phosphatases, glycosylases and transferases for scientific and research use; restriction enzymes for scientific and research use; media supplements, namely, reagents for scientific and research use; lymphokines, namely, reagents for scientific and research use; cytokines, namely, reagents for scientific and research use; kits for molecular biological research, namely, DNA cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, genomic cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transfection kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, purification kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, polymerase chain reaction or PCR related cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, ligase chain reaction or LCR kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, library construction kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, labeling kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, mutagenesis kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for scientific and research use, namely, protein analysis kits said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transcription kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, translation kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; and kits for molecular biological research, namely, in situ hybridization kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2009-09-26 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-09-28 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2009-12-20 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2009-12-28 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2009-12-28 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2009-12-28 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-06-28 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-06-28 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-06-29 | 9 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2010-07-26 | 10 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2010-07-26 | 11 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2010-07-26 | 12 GNRN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2010-11-16 | 13 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2010-11-16 | 14 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-01-26 | 15 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2011-01-28 | 16 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-02-03 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-02-03 | 18 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2011-03-07 | 19 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2011-03-07 | 20 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2011-03-07 | 21 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-09-06 | 22 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-09-15 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-09-15 | 24 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-09-15 | 25 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-09-23 | 26 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-11-01 | 27 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-11-01 | 28 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2012-01-17 | 29 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2017-01-17 | 30 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2017-03-16 | 31 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-05-04 | 32 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2017-05-04 | 33 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2017-05-04 | 34 NA85 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-06-08 | 35 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-06-08 | 36 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-06-08 | 37 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-06-08 | 38 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-06-08 | 39 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-25 | 40 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-25 | 41 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | 2020-08-25 | 42 EWOR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-25 | 43 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-01-17 | 44 REM2 E:E-Mail |
| NOTICE OF SUIT | 2021-01-28 | 45 NOSU I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2022-01-18 | 46 E89R I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-02-23 | 47 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-02-23 | 48 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-02-23 | 49 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-02-23 | 50 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-02-23 | 51 CHAN I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-06-24 | 52 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-06-24 | 53 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2022-06-24 | 54 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-06-24 | 55 NA89 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 